Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Surfactant Positive Airway Pressure and Pulse Oximetry Trial (SUPPORT) in Extremely Low Birth Weight Infants
Brief Summary: This study compared the use of continuous positive airway pressure initiated at birth with the early administration of surfactant administered through a tube in the windpipe within 1 hour of birth for premature infants born at 24 to 27 weeks gestation. In addition, these infants within 2 hours of birth, had a special pulse oximeter placed to continuously monitor their oxygen saturation in two different target ranges (85-89% or 91-95%). This study helped determine whether or not these two management strategies affect chronic lung disease and survival of premature infants.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Titration of oxygen therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Titration of oxygen therapy | Intervention Type: OTHER; Name: Titration of oxygen therapy; Assigned to Arm(s): 1, 2
B: Arm Label: RFM visible; Type: EXPERIMENTAL; Interventions: Device: New Life Box Respiratory Function Monitor | Arm Label: RFM masked; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: New Life Box Respiratory Function Monitor; Assigned to Arm(s): RFM visible
C: Arm Label: RMC only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CLAC slow; Type: ACTIVE_COMPARATOR; Interventions: Device: Closed-loop automatic oxygen control (CLAC) slow in addition to RMC | Arm Label: CLAC fast; Type: EXPERIMENTAL; Interventions: Device: Closed-loop automatic oxygen control (CLAC) fast in addition to RMC | Intervention Type: DEVICE; Name: Closed-loop automatic oxygen control (CLAC) fast in addition to RMC; Assigned to Arm(s): CLAC fast | Intervention Type: DEVICE; Name: Closed-loop automatic oxygen control (CLAC) slow in addition to RMC; Assigned to Arm(s): CLAC slow
D: Arm Label: Surfactant and Low Oxygen; Type: EXPERIMENTAL; Interventions: Drug: Surfactant, Drug: Supplemental oxygen with target saturation of 85 to 89% | Arm Label: Surfactant and High Oxygen; Type: EXPERIMENTAL; Interventions: Drug: Surfactant, Drug: Supplemental oxygen with target saturation of 91 to 95% | Arm Label: CPAP and Low Oxygen; Type: EXPERIMENTAL; Interventions: Device: Continuous Positive Airway Pressure (CPAP), Drug: Supplemental oxygen with target saturation of 85 to 89% | Arm Label: CPAP and High Oxygen; Type: EXPERIMENTAL; Interventions: Device: Continuous Positive Airway Pressure (CPAP), Drug: Supplemental oxygen with target saturation of 91 to 95% | Intervention Type: DRUG; Name: Surfactant; Assigned to Arm(s): Surfactant and High Oxygen, Surfactant and Low Oxygen | Intervention Type: DEVICE; Name: Continuous Positive Airway Pressure (CPAP); Assigned to Arm(s): CPAP and High Oxygen, CPAP and Low Oxygen | Intervention Type: DRUG; Name: Supplemental oxygen with target saturation of 85 to 89%; Assigned to Arm(s): CPAP and Low Oxygen, Surfactant and Low Oxygen | Intervention Type: DRUG; Name: Supplemental oxygen with target saturation of 91 to 95%; Assigned to Arm(s): CPAP and High Oxygen, Surfactant and High Oxygen

Answer: D